Active Clinical Trials

Response Evaluation in Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 150

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Retrospective

Study ID Numbers: ONC/OSS-02/2009

Study First Received: August 6, 2009

Last Updated: August 5, 2015

Estimated Primary Completion Date: August 2015

 

Primary Outcome Measures:

To validate a semi-automated iterative threshold-based region growing algorithm in a previously published series of patients.|To extend the analysis to another series of consecutive patients with MALIGNANT PLEURAL MESOTHELIOMA treated with first-line pemetrexed-based chemotherapy, and to perform a combined analysis of the two groups.|To validate the new liver-based threshold semi-automated algorithm on the GE ADW4.6 workstation with the algorithm validated in step 1 in the same subset of patients.

Sponsors and Collaborators:

Istituto Clinico Humanitas

Website Link: https://ClinicalTrials.gov/show/NCT00969098

Leave a Reply

Call Now ButtonCall Now